• Login
    View Item 
    •   SMARTech Home
    • Center for Health Analytics and Informatics (CHAI)
    • Center for Heath Analytics and Informatics Seminar Series
    • View Item
    •   SMARTech Home
    • Center for Health Analytics and Informatics (CHAI)
    • Center for Heath Analytics and Informatics Seminar Series
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Translating from Chemistry to Clinic with Deep Learning: Modeling the Metabolism and Subsequent Reactivity of Drugs

    Thumbnail
    View/Open
    swamidass.mp4 (173.2Mb)
    swamidass_videostream.html (1.006Kb)
    transcription.txt (55.04Kb)
    Date
    2018-04-12
    Author
    Swamidass, S. Joshua
    Metadata
    Show full item record
    Abstract
    Many medicines become toxic only after bioactivation by metabolizing enzymes. Often, metabolic enzymes transformed them into chemically reactive species, which subsequently conjugate to proteins and cause adverse events. For example, carbamazepine is epoxidized by P450 enzymes in the liver, but then conjugates to proteins, causing Steven Johnsons Syndrome in some patients. The most difficult to predict drug reactions, idiosyncratic adverse drug reactions (IADRs), often depend on bioactivation. Our group has been using deep learning to model the metabolism of diverse chemicals, and the subsequent reactivity of their metabolites. Deep learning systematically summarizes the information from thousands of publications into quantitative models of bioactivation, modeling precisely how medicines are modified by metabolic enzymes. These models are giving deeper understanding of why some drugs become toxic, and others do not. At the same time, deep learning can be used to understand drug toxicity as it arises in clinical data, and why some patients are affected, but not others. A conversation between the basic and clinical sciences is now possible, where patient outcomes can be understood in light of bioactivation mechanisms, and these mechanisms can explain why some patients are susceptible to drug toxicity, and others are not.
    URI
    http://hdl.handle.net/1853/59640
    Collections
    • Center for Heath Analytics and Informatics Seminar Series [15]

    Browse

    All of SMARTechCommunities & CollectionsDatesAuthorsTitlesSubjectsTypesThis CollectionDatesAuthorsTitlesSubjectsTypes

    My SMARTech

    Login

    Statistics

    View Usage StatisticsView Google Analytics Statistics
    facebook instagram twitter youtube
    • My Account
    • Contact us
    • Directory
    • Campus Map
    • Support/Give
    • Library Accessibility
      • About SMARTech
      • SMARTech Terms of Use
    Georgia Tech Library266 4th Street NW, Atlanta, GA 30332
    404.894.4500
    • Emergency Information
    • Legal and Privacy Information
    • Human Trafficking Notice
    • Accessibility
    • Accountability
    • Accreditation
    • Employment
    © 2020 Georgia Institute of Technology